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Receptor characteristics for atria1 natriuretic peptides (ANP) were demonstrated in the permanent issue 
culture system of vascular smooth muscle cell (VSMC) line. Y-ANP exhibited reversible and saturable 
binding to A10 rat VSMC, and the equilibrium dissociation constant, Kd was 157 pM and maximal binding 
capacity, Bmax amounted to 115 fmol/mg of protein. Binding of the 12SI-ligand was highly specific for certain 
potently displacing ANP analogues with inhibition constants (K, values) in the nano- or even subnanomolar 
concentration range. Pretreatment of VSMC with ANP yielded receptor desensitization to one half of the 
ANP receptor density, and supports the conclusion of receptor autoregulation byANP in A10 VSMC. The 
receptor coupled intracellular cGMP system was stimulated, and thus demonstrates the application of A 10 
cells as a model for the study of ANP receptor interaction involved in vascular smooth muscle relaxation. 
Atria1 natriuretic peptide Receptor binding cyclic GMP cyclic AMP Receptor desensitization 
(Vascular smooth muscle, AI0 cell, CRL 1476 cell) 
1. INTRODUCTION 
Mammalian atria contain powerful natriuretic 
and vasoactive peptides (review [ 11) termed collec- 
tively as atria1 natriuretic peptides (ANP). They 
represent a new class of hormones synthesized in 
and released from mammalian atria into the cir- 
culation dependent on the volume status [l-2], 
and aside from their key role in regulating fluid 
volume and water-electrolyte balance ANPs also 
exert a potent effect on blood pressure [I]. Recent- 
ly, ANP was shown to bind to primary cultures of 
smooth muscle cells derived from rat or bovine 
aorta explant [4-61. The present report documents 
binding characteristics of ‘*‘I-ANP, cGMP 
stimulation and ANP receptor down-regulation 
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using the A10 vascular smooth muscle permanent 
cell (VSMC) line [7]. 
2. MATERIALS AND METHODS 
2.1. Preparation of radiolabelled rat ANP 
Iodination of rat ANP III was carried out as 
described [2] using the chloramine T method. 1251- 
ANP was purified by reverse-phase chromatog- 
raphy on RP 18 with an acetonitrile/TFA (0.1070) 
gradient [2]. The resulting specific activity of the 
radioligand was about 1900 Ci/mmol. 
2.2. Cell cultures 
Cells were cultured in Dulbecco’s MEM contain- 
ing FCS (lo%), L-glutamine (6.8 mM), Hepes 
(20 mM) and penicillin/streptomycin (50 IU/ml, 
each) using an atmosphere of COz/air (1: 19). At 
confluence cells were trypsinized and subcultured 
in tissue culture flasks. For receptor binding and 
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cyclic nucleotide stimulation experiments cells 
were removed by trypsinization (O.OSYo), counted 
and seeded onto 24-well tissue culture clusters of 
costar (Greiner, Nurtingen, FRG) at a density of 2 
x lo5 cells/well. Experiments were started after 
cells became adherent for about 16 h. 
(50 mM, pH 6.2) and cGMP and CAMP were then 
determined according to the technical guide of the 
assay kits (NEN). 
2.6. Materials 
2.3. Down-regulation of vascular ANP receptors 
After the inoculation period A10 VSMC were in- 
cubated in fresh Dulbecco’s MEM culture medium 
without or with unlabelled ANP (0.01 ,uM or 
1 PM) at 37°C for 20 h. ANP receptor affinity and 
capacity were then estimated by radioligand 
binding assays as given below. 
The rat aortic smooth muscle cell line A10 (CRL 
1476) was obtained from the American Type 
Culture Collection, ATCC (Bethesda, MD). Tissue 
culture media and admixtures were purchased 
from Boehringer Mannheim or Gibco, Karlsruhe, 
FRG. Nalz51, cGMP and CAMP kits were from 
New England Nuclear (Boston, MA), ANP and 
their fragments were from Peninsula Labs; all 
chemicals used were reagent grade. 
2.4. Binding assay 
Cultured A10 cells were washed twice with 
warmed binding medium (Dulbecco’s MEM con- 
taining 0.05% BSA, pH 7.4 at 37°C). In a final 
volume of 1 ml, cells were incubated at 37°C in 
binding medium containing the indicated concen- 
tration of 12’1-ANP and various additives, e.g., 
peptides as displacer. After the indicated time in- 
tervals, the reaction was terminated by rapidly 
aspirating the incubation fluid and washing the 
monolayers twice with 2 ml of ice-cold binding 
medium. Cells were then disintegrated by 0.5 ml of 
NaOH/Triton X-100 (0.2 M/0.1%), and cellular 
radioactivity was measured by gamma-scintillation 
spectrophotometry. Protein was measured as 
described [8] with serum albumin as the standard. 
Data were calculated and plotted according to 
Scatchard, and displacement experiments were 
analyzed with computer programmes. 
3. RESULTS AND DISCUSSION 
1251-ANP interacted with membrane fractions 
from bovine adrenal cortices; however, specific 
binding in this preparation was low and ranged 
between 15 and 20%, only. Thus, intact A10 
VSMC in monolayer cultures were used for recep- 
tor binding studies. Specific binding to cultured 
VSMC was linearly proportional to cell density up 
to 5 x lo6 cells/well; thus, receptor binding studies 
were carried out in the linear range using 2 x lo5 
7- 
6- 
2.5. Determination of cellular cGA4P and CAMP 
A10 cultured VSMC were washed twice with 
assay medium (Dulbecco’s MEM containing 
0.05% BSA) and then incubated in a final volume 
of 0.5 ml of assay medium with or without 
isobutylmethylxanthine (0.1 mM) for 5 min. ANP 
or their fragments were added and further in- 
cubated for the indicated time intervals. Incuba- 
tion was terminated by removing the assay medium 
and by adding 2 ml of trichloroacetic acid (10%). 
The disintegrated cell suspensions were aspirated 
and centrifuged. The supernatant was extracted 
with four portions of ethylether, and the aqueous 
phase was finally lyophilized overnight. The 
residue was dissolved in Na-acetate buffer 
Fig. 1. Time dependence of 12?-ANP binding to cultured 
A10 vascular smooth muscle cells. The figure shows the 
time course of r2’I-ANP association to intact cell 
cultures as specific (0) and non-specific (0, presence of 
1 pM ANP) binding. Results presented are the mean + 
SD of 6 separate experiments. 
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cells/well (approx. 200 pg of protein). Addition of 
1 ,uM ANP (non-specific binding) to the assay 
displaced 75-90% of the total “‘1-ANP binding, 
and the amount of radioactivity adherent to the 
plastic surface ranged between 1.7 and 2.6%) only. 
As checked by HPLC [2] the iodinated radioligand 
remains stable under the experimental conditions 
reported here. 
Specific binding (b,) of ‘*‘I-ANP to A10 VSMC 
was a time-dependent process (fig.l), and steady- 
state values were reached after 30 min and re- 
mained constant over a period of more than 2 h. 
Binding of 1251-ANP in the presence of 1 PM 
unlabelled ANP (non-specific binding, b& also 
occurred time-dependently and amounted to 
20-30% of specific binding. 
The specific binding of ‘*‘I-ANP was saturable 
and plateaus were achieved between 250 and 
300 pM of radioligand (fig.%). Scatchard analyses 
LL’ I I 
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Fig.2. Saturation isotherm of ‘251-ANP binding to 
cultured A10 vascular smooth muscle cells. Cells were 
incubated at least in triplicate with r2’I-ANP, 
lo-380 pM, in the presence or absence of unlabelled 
ANP. Specific binding (0, fmol/mg of protein) was 
calculated as the difference between total binding and 
that not displaced by excess (1 PM) of ANP. The latter 
(non-specific binding) ranged between 10 and 25% (see 
text). Inset: Scatchard analysis of specific binding data 
(B, bound ligand; F, free radioligand) revealed linearity 
and indicated one binding site with an equilibrium 
dissociation constant Kd = 0.13 nM (reciprocal of the 
slope value) and maximal binding, B,, of 120 fmol/mg 
of protein (r = 0.971; intercept on abscissa). The 
experiment was repeated several times with different cell 
preparations and yielded identical results (r > 0.95). 
of the saturation isotherms (fig.2, inset) revealed a 
straight line indicating the presence of a single 
binding site. The equilibrium dissociation cons- 
tant, Kd was 157 f 29 pM (n = 6; r > 0.95), and 
the number of receptor binding sites (capacity), 
B,, equivalent o 115 + 8 fmol/mg protein (n = 
6; r > 0.95). Similar results were reported for ANP 
binding to crude rabbit aortic membranes [9], and 
to primary cultures of smooth muscle cells from 
bovine and rat aorta [4,6]. 
Pretreatment of A10 VSMC with unlabelled 
ANP for 16 h resulted in a marked reduction of 
the total number of receptors without major 
alteration in the affinity. Scatchard analyses of the 
‘*‘I-ANP specific binding to A10 cells without 
ANP pretreatment showed a receptor capacity of 
about 120 fmol/mg protein. The reduction of 
receptor density was gradual and related to the 
ANP concentration applied (fig.3): lo-* M and 
10m6 M ANP pretreatment diminished ANP recep- 
tor density to 100 and 60 fmol/mg protein, respec- 
tively. Data presented substantiate the conclusion 
of receptor autoregulation by ANP in smooth 
RECEPTOR DESENSITATION 
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Fig.3. ANP receptor desensitization. Scatchard analyses 
of “‘1-ANP specific binding to cultured A10 vascular 
smooth muscle cells pretreated for 16 h without 
(control) or with unlabelled ANP (0.01 pM; 1 PM 
ANP). Results show no major changes in receptor 
affinity, but binding capacity was reduced concentra- 
tion-dependently from 120 fmol/mg of protein (e, 
control) to 100 (0, 0.01 pM ANP) or 60 fmol/mg of 
protein (0, 1 CM ANP), respectively. Data are 
representative results of 3 separate experiments. 
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muscle cells [ 10,111, and consequently receptor 
desensitization may also occur under certain 
pathophysiological conditions linked to exag- 
gerated ANP levels in the blood circulation. 
The pharmacological manner of the “‘I-ANP 
receptor sites is demonstrated by displacement 
studies with various ANP. Fig.4 presents an exam- 
ple of such competitive 12’1-ANP binding ex- 
periments in A10 VSMC using unlabelled ANP 
derivatives. Rat ANP and a-human ANP (l-28) 
both inhibited the binding of 12’1-ANP to the 
receptor concentration-dependently with apparent 
inhibition constants (Ki values) of 71.5 + 8 pM (n 
= 8) for both peptides. 
Different atria1 natriuretic peptides and 
fragments generally inhibit the binding of 12?- 
ANP to A10 VSMC (table 1). Shortening of the C- 
terminal amino acid sequence, e.g., ANP I, ANP 
II resulted in reduced binding of the peptides to the 
ANP receptor. In contrast, fragment (7-28), a 
peptide without the N-terminal sequence, still ex- 
erted a similar inhibitory activity to ANP III, r- 
ANP (l-28) and h-ANP (l-28). Fragments 
without the intramolecular disulfide bond, e.g., 
fragments (13-28), (18-28), (l-11), totally lost 
the ability to interact with the ANP receptor. 
These structure-activity relationships correspond 
‘=I-ANP A10 VASCULAR SMOOTH 
MUSCLE CELLS 
100 - $1 
. h-ANP 
20 - 
0 r-ANP 
“\\ L- 
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12 11 10 9 a 7 6 
-LOGlo DISPLACER [Ml 
Fig.4. Displacement experiments using “‘I-ANP (< 100 
PM) and the unlabelled peptides, rat ANP (0) and 
human ANP (A) dissolved in tissue culture medium. 
Total binding to cultured A10 vascular smooth muscle 
cells is plotted against - log10 of displacer concentration 
[Ml. Data are the means of 3-5 separate experiments in 
triplicate with less than 5% standard eviation. 
well with the vascular reactivity of various ANP 
derivatives in the rabbit aortic strip preparation 
WI. 
Table 1 
Inhibition of 12%ANP binding and effect on cyclic nucleotides by 
various atria1 natriuretic peptides in cultured A10 vascular smooth 
muscle cells 
Peptides Inhibi- cGMP CAMP 
tion (fmol/2 x 10’ (pmol/2 x lo5 
(070) cells) cells) 
ANP I 
ANP II 
ANP III 
ANP (l-28) 
h-ANP (l-28) 
Fragment 7-28 
Fragment 13-28 
Fragment 18-28 
Fragment 1 - 11 
Control 
40 
60 
85 
90 
90 
85 
0 
0 
0 
- 
n.d. n.d. 
n.d. n.d. 
300 18 
290 19 
320 16 
320 _ 
55 _ 
65 - 
58 - 
60 21 
Inhibition of 12’1-ANP binding and cyclic nucleotide assays were 
performed as described in section 2. Results presented are the 
mean of 6 separate experiments with less than 10% SD 
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The functional coupling of the ANP receptor to 
intracellular target sites is demonstrated by 
measuring cellular levels of cGMP and CAMP in 
the presence of several ANP analogues. Rat ANP, 
a-human ANP (l-28) and fragment (7-28) 
enhanced cGMP concentration in A10 VSMC to 
almost equal amounts, whereas intracellular 
CAMP levels remain unaffected by the com- 
pounds. Stimulation of cGMP by atrial natriuretic 
peptides was recently reported also in rat and 
bovine aortic as well as in endothelial cells [4,6], 
and thus suggests the particular involvement of the 
intracellular cGMP level in its vasorelaxant effect, 
but not the CAMP system. 
In summary, the results of the binding 
characteristics and the subsequent stimulation of 
the intracellular cGMP system presented here sup- 
port the conclusion that the modulation of specific 
receptive sites for ANP by various ANP 
derivatives and the receptor coupled intracellular 
events are studied well in the permanent tissue 
culture system of A10 vascular smooth muscle 
cells. 
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